We are live on ! Find out more
LJPC

La Jolla Pharmaceutical Company
LJPC

Delisted

LJPC was delisted on the 19th of August, 2022.

Back to rankings

71 hedge funds and large institutions have $382M invested in La Jolla Pharmaceutical Company in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

839% more call options, than puts

Call options by funds: $7.65M | Put options by funds: $815K

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

49% more capital invested

Capital invested by funds: $256M → $382M (+$126M)

19% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 21

3% less funds holding

Funds holding: 73 → 71 (-2)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

Holders
71
Holders Change
-2
Holders Change %
-2.74%
% of All Funds
1.89%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.11%
New
8
Increased
25
Reduced
21
Closed
10
Calls
$7.65M
Puts
$815K
Net Calls
+$6.84M
Net Calls Change
+$4.49M

Top Buyers

Rank Fund Capital Flow
1
PC
PointState Capital
New York
+$3.77M
2
BC
Broadfin Capital
New York
+$3.12M
3
TCM
Tang Capital Management
California
+$2.62M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.22M
5
EI
EAM Investors
California
+$678K

Top Sellers

Rank Fund Capital Flow
1
GIM
Granahan Investment Management
Massachusetts
-$2.78M
2
SM
Sabby Management
Florida
-$1.6M
3
ACA
Avoro Capital Advisors
New York
-$1.12M
4
BGA
Belmont Global Advisors
Texas
-$960K
5
LCM
Landscape Capital Management
New Jersey
-$852K
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
26
California Public Employees Retirement System
California
$887K – – –
EI
27
EAM Investors
California
$856K +$678K +35,977 New
PAWC
28
P.A.W. Capital
Connecticut
$833K -$283K -15,000 -30%
HCM
29
Highbridge Capital Management
New York
$818K +$648K +34,374 New
EA
30
Emerald Acquisition
Washington
$726K +$575K +30,502 New
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$699K +$3.77K +200 +0.7%
Bank of America
32
Bank of America
North Carolina
$687K +$528K +28,010 +3,288%
Swiss National Bank
33
Swiss National Bank
Switzerland
$580K – – –
SCA
34
Secor Capital Advisors
New York
$571K -$263K -13,982 -37%
TA
35
Teachers Advisors
New York
$538K -$8.35K -443 -2%
HCM
36
Hollencrest Capital Management
California
$526K – – –
Charles Schwab
37
Charles Schwab
California
$514K – – –
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
$434K +$96.4K +5,117 +39%
Wells Fargo
39
Wells Fargo
California
$383K -$38.7K -2,055 -11%
VEA
40
Virtus ETF Advisers
New York
$340K – – –
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$329K +$4.15K +220 +2%
BBA
42
Baker Bros. Advisors
New York
$327K – – –
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$324K – – –
Capital Fund Management (CFM)
44
Capital Fund Management (CFM)
France
$321K +$255K +13,510 New
MLICM
45
Metropolitan Life Insurance Company (MetLife)
New York
$317K – – –
NPC
46
National Planning Corporation
California
$305K – – –
AllianceBernstein
47
AllianceBernstein
Tennessee
$302K – – –
CS
48
Credit Suisse
Switzerland
$277K -$397K -21,082 -64%
Prudential Financial
49
Prudential Financial
New Jersey
$250K +$198K +10,520 New
UBS Group
50
UBS Group
Switzerland
$249K -$21.4K -1,138 -10%
1
2
3 4

LJPC Hedge Fund Activity: Q3 2016 in Review

71 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q3 2016, worth a combined $382M — up 49% from $256M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of LJPC and 8 opened new positions — a net loss of 2 holders — while 21 trimmed existing stakes and 25 added.

The largest buyer was PointState Capital, opening a new position worth an estimated $3.77M. The largest seller was Granahan Investment Management, cutting an estimated $2.78M.

  • 71 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q3 2016, down from 73 in Q2 2016.
  • Funds reported $382M of La Jolla Pharmaceutical Company stock for Q3 2016, up 49% quarter-over-quarter.
  • 8 funds opened new La Jolla Pharmaceutical Company positions in Q3 2016 and 10 closed out, a net change of -2 holders.
  • The largest La Jolla Pharmaceutical Company buyer in Q3 2016 was PointState Capital, an estimated $3.77M added.
  • The largest La Jolla Pharmaceutical Company seller in Q3 2016 was Granahan Investment Management, an estimated $2.78M sold.

Based on aggregated 13F filings for Q3 2016.